EMEA-002266-PIP01-17

Key facts

Active substance
Recombinant human acid ceramidase (RVT-801)
Therapeutic area
Other
Decision number
P/0319/2018
PIP number
EMEA-002266-PIP01-17
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Farber disease
Route(s) of administration
Intravenous use
Contact for public enquiries
Aceragen Inc.

Tel. +15182583364
E-mail: regulatory@aceragen.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating